Gastrointestinal Infections in Immunocompromised Populations

Gastrointestinal (GI) infections pose a significant threat to immunocompromised populations, including individuals undergoing chemotherapy, organ transplant recipients, patients with HIV/AIDS, and those receiving immunosuppressive therapies for autoimmune disorders. In these vulnerable groups, the immune system's diminished capacity to combat infections makes them highly susceptible to a wide range of GI pathogens, including common bacteria, viruses, fungi, and parasites. Even pathogens that typically cause mild illness in immunocompetent individuals can lead to severe, prolonged, and sometimes life-threatening complications in those with compromised immunity. The clinical management of these infections is further complicated by atypical presentations, the potential for rapid progression, and the risk of widespread dissemination beyond the gastrointestinal tract.



Addressing GI infections in immunocompromised populations requires a comprehensive and multidisciplinary approach that includes early diagnosis, tailored therapeutic interventions, and preventive strategies such as vaccination and prophylactic antimicrobials. The emergence of antimicrobial resistance among GI pathogens presents an additional challenge, necessitating the development of new treatment protocols and the judicious use of existing antimicrobials. Furthermore, the complex interplay between the host immune response and the gut microbiome in these patients underscores the need for personalized medicine approaches to optimize treatment outcomes. As the number of individuals with immunocompromising conditions continues to rise globally, advancing research in this area is crucial for improving patient care and reducing the burden of GI infections in this high-risk population.



Submission of original research involving clinical data, reviews and minireviews, methods, resources, and perspectives on future directions and challenges are welcome. Potential topics may include, but are not limited to:



1. The Impact of Immunosuppressive Therapy on Susceptibility to Gastrointestinal Infections

• Investigate how different immunosuppressive drugs used in conditions like organ transplantation or autoimmune diseases affect the risk and severity of GI infections.



2. Clinical Outcomes of Gastrointestinal Infections in HIV/AIDS Patients in the Era of Antiretroviral Therapy

• Explore the changing landscape of GI infections in HIV-positive individuals, focusing on how antiretroviral therapy has altered infection patterns and outcomes.



3. Antimicrobial Resistance in Gastrointestinal Pathogens Among Immunocompromised Patients

• Examine the prevalence and implications of antimicrobial-resistant GI infections in immunocompromised populations and discuss strategies for management and prevention.



4. The Role of the Gut Microbiome in Modulating GI Infection Risk in Immunocompromised Individuals

• Study the interaction between the gut microbiome and the immune system in immunocompromised patients, and how this relationship influences susceptibility to GI infections.



5. Prophylactic Strategies for Preventing Gastrointestinal Infections in Immunocompromised Populations

• Review current prophylactic measures, including vaccinations, antimicrobial prophylaxis, and dietary modifications, and their effectiveness in preventing GI infections in high-risk groups.



6. Diagnostic Challenges and Innovations in Detecting Gastrointestinal Infections in Immunocompromised Hosts

• Discuss the difficulties in diagnosing GI infections in immunocompromised patients due to atypical presentations and the development of novel diagnostic tools to improve early detection.



7. The Burden of Viral Gastroenteritis in Immunocompromised Children: Epidemiology and Management

• Focus on the epidemiology, clinical management, and outcomes of viral GI infections, such as Norovirus and Cytomegalovirus, in immunocompromised pediatric patients.



8. Fungal Gastrointestinal Infections in Immunocompromised Individuals: Emerging Pathogens and Treatment Approaches

• Explore the increasing incidence of fungal GI infections, such as those caused by Candida and Aspergillus species, and discuss the challenges in their management.



9. Outcomes of Gastrointestinal Infections in Solid Organ Transplant Recipients: Risk Factors and Preventive Strategies

• Analyze the incidence, risk factors, and outcomes of GI infections in organ transplant recipients, and evaluate the effectiveness of current preventive and therapeutic strategies.



10. Long-Term Health Impacts of Gastrointestinal Infections in Immunocompromised Populations

• Investigate the long-term effects of severe GI infections on overall health, quality of life, and survival in immunocompromised patients, including potential for chronic complications.